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1. INTRODUCTION 
1.0 Diabetes mellitus 
 In the years between 1958 and 1993, the number of people diagnosed 
with diabetes multiplied five – fold1. In 1994, 135 million patients world - wide 
were living with Diabetes mellitus. By the year 2025, it is estimated that this 
figure would increase to more than 300 million2. 
1.1 Diabetes Mellitus - Definition 
 Diabetes mellitus is a chronic metabolic disorder, predominantly of 
carbohydrates, which has hereditary and environmental risk factors. According 
to the criteria of WHO and the ADA (American Diabetes Association) of 
19973, a diagnosis can be established on the basis of fasting plasma glucose 
levels of : 
1. 7.8 mmol/L (126 mg/dl) or above (with or without the presence 
of the classic signs such as polydipsia, tiredness, unexplained 
weight loss or pruritus). 
2. 11.1 mmol/L (200mg/dl) and above measured at random and 
coexisting with the disease symptoms mentioned previously. 
3. 11.1 mmol/L (200mg / dl) measured two hours after a 
standardized oral glucose tolerance test. 
 
 
 
 
 
 
 
 
2.0 AIM AND OBJECTIVES OF THE STUDY 
With the projected 14% prevalence rate of Diabetes Mellitus in Indian 
population and about 5 – 10% of them developing foot infections and 
associated foot lesions, it becomes imminent for the health care system to put 
in practice a logistically feasible management strategy for Diabetic foot in 
Government Hospitals. This becomes important in view of the fact that over 
80% of general population in India approach only Government Hospitals for 
their health care requirements. 
      With this aim in mind, the present study was planned and conducted. The 
objectives of the project are: 
2.1. To study the clinical pattern of foot infections in Diabetic 
patients. 
2.2. To study the effect of Glycaemic status in controlling infection 
 
 
 
2.3.    To analyze the risk factors leading to complications in Diabetic 
Foot-infections                                                                                                          
            2.4. To study the outcome of the treatment modalities and suggest a 
patient friendly hospital management strategy for Diabetic foot  
 
 
 
 
3.0 REVIEW OF LITERATURE 
3.1 Definition and History of the Diabetic foot  
3.1.1 Definition 
 The World Health organization defines the diabetic foot as an infection, 
ulceration and / or destruction of deep tissues associated with neurological 
abnormalities and various degrees of peripheral vascular disease in the lower 
limb. In Dutch consensus, the diabetic foot is defined as a diversity of foot 
abnormalities caused by neuropathy, micro- angiopathy, limited joint mobility 
and other consequences of metabolic disturbances, mostly occurring in 
combination, in patients with diabetes mellitus. Both definitions are 
descriptions of causal factors and resulting foot disorders. This emphasizes that 
the diabetic foot is more a syndrome rather than a diagnosis. 
3.1.2 History  
`Pyrce described, `a case of a perforating ulcer in diabetes and atactic 
symptoms, as early as 18874. In 1934, Elliot Joslin, one of the pioneers of 
diabetology, published an article entitled, `The menace of diabetic gangrene', in 
which, Joslin described the common causes of diabetic foot lesions5, and he 
wrote, "that gangrene is not heaven sent, but is earth born". However, it was 
not until the 1950s that diabetic neuropathy, ischemia and infection were 
finally recognized as precondition of foot complications in diabetics - facts that 
still hold good today. 
 
 
 
3.2 Epidemiology of the diabetic foot syndrome 
 A quarter of the diabetic population is at increased risk of foot injuries 
as a result of the presence of diabetic neuropathy or an arterial circulatory 
disorder. Every year 3 to 7% of diabetics suffer a foot lesion for the first time. 
 Foot ulcers occur in approximately 15% of people with diabetes which 
accounts for 25% of all hospital admissions with the hospital stay being 60% 
longer than the stay for other causes and the risk of amputation is 15 to 40 
times greater in diabetics than in others6. 
 Diabetic foot ulcers account for more than 50% of non traumatic 
amputations and are associated with high rates of mortality, re-amputation and 
contra lateral limb amputation. 
           India has 30 million diabetics at present and in the year 2025 India is 
predicted to have 57 million diabetics.  
3.2.1 Incidence in India 
 Foot Ulcer     : 1-4% 
 Toe amputation    : 2.6% 
 Below knee amputation    : 1.6% 
 Prevalence of diabetic foot in India          : 5.3 - 10.5%  
3.2.2 Socio - economic impact of the diabetic foot syndrome 
           Overall, the costs generated by diabetes are about three times as high as 
those produced by non - diabetics. Foot complications constitute a major 
proportion of these. 
 
 
 
 With primary healing, about 30% of the total cost derives from 
hospitalization, but where amputation is required this figure is 65% to 80%. 
The average healing duration for diabetic foot lesions is about four months.  
Ten percent of all lesions persist for more than one year, which incurs 
further costs for outpatient care. Fifteen percent of all foot ulcers in diabetics 
do not heal before the patient's death7. 
 Most important cost item is namely the "cost" to the patient themselves 
in terms of the emotional trauma suffered and the loss of quality of life and 
independence8a.  
3.3 CLASSIFICATION OF DIABETIC FOOT. 
 
3.3.1 The Meggitt – Wagner classification is the most well-known and 
validated system for foot – ulcers8b. 
Grade   Description 
Grade 0  Pre or post-ulcerative lesion completely epithelialized. 
Grade 1  Superficial, full thickness ulcer limited to the dermis, not 
extending to the subcutis 
Grade 2  Ulcer of the skin extending through the subcutis with exposed 
tendon or bone and without osteomyelitis or abscess 
formation. 
Grade 3  Deep ulcers with osteomyelitis or abscess formation. 
Grade 4  Localized gangrene of the toes or the forefoot. 
Grade 5  Foot with extensive gangrene 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 The University of Texas classification system9 for Diabetic foot 
wounds 
 
Grade 
 
Stage 0 1 2 3 
A Pre or post-
ulcerative lesion 
completely 
epitheliasied 
Superficial 
Wound not 
involving 
tendon, capsule 
or bone 
Wound 
penetrating 
to tendon or 
capsule 
Wound 
penetrating 
to bone or 
joint 
B with infection with infection with 
infection 
with 
infection 
C with ischemia with ischemia with 
ischemia 
with 
ischemia 
D with infection & 
ischemia 
with infection 
& ischemia 
with 
infection & 
ischemia 
with 
infection & 
ischemia 
 
3.3.3 Edmonds & Foster classification 
Based on clinical tests and determination of the ankle brachial pressure 
index. 
   Neuropathic 
Foot ulcers 
   Neuro-ischemic 
3.3.4 Broadsky suggested the `depth-ischemia classification' 
 
Which is a modification of the Meggitt - Wagner Classification. 
 
 A - Not ischemic 
  
 B - Ischemic without gangrene 
  
 C - Partial gangrene of the foot 
 
 D - Complete foot gangrene with grades 1-3 (similar to the  
Meggitt – Wagner classification) 
 
 
 
3.3.5 Macfarlane and Jeffcoate proposed the S(AD)AD classification for 
diabetic foot  ulcers10. 
According this system, ulcers are classified on the basis of  
           Size, (Area & Depth) 
           Presence of Sepsis 
 Arteriopathy 
 and  
           Denervation 
3.4 RISK FACTORS FOR FOOT COMPLICATIONS IN 
DIABETICS: 
Classification of categories of diabetic patients based on the risk for 
ulceration 11. 
3.4.1 Risk category 
0. Protective sensation is intact, the patient may have foot deformity. 
1. Loss of protective sensation. 
2. Loss of protective sensation high. Plantar pressure or callosities or 
history of foot ulcer. 
3. Loss of protective sensation and history of ulcer and severe foot or 
toe deformity and / or limited joint mobility; significant peripheral 
vascular disease. 
 
 
 
3.5 CLINICAL PATTERN OF DIABETIC FOOT LESIONS 
(I)       Infections    
(II)     Ulcers 
(III) Gangrene    
(IV) Joint lesions 
3.5.1 Infections 
 Diabetic foot infections are categorized as mild, moderate or severe. 
3.5.1.1 Mild infections are superficial infections confined to the skin and the 
subcutaneous fat with minimal or no purulence or cellulitis. This is 
otherwise known as non-limb threatening infections 
3.5.1.2Moderate infections are deep and may involve fascial, muscles, tendons, 
joints or bones. They may present as cellulitis of 0-2 cms in diameter or 
a plantar abscess, and they may cause systemic symptoms. They impose 
a certain risk of amputation. 
3.5.1.3Severe infection of a foot ulcer is a deep infection with more than 2 cm 
of cellulitis, lymphangitis, gangrene and or necrotizing fascitis, 
threatening limb loss and causing systemic toxicity. Absence of 
symptoms or signs of systemic illness does not exclude a limb 
threatening infection. 
Moderate and Severe infections are collectively known as limb-
threatening infections.  
 
 
 
3.5.1.4 Bacterial Infections 
Staphylococcus aureus or β - hemolytic streptococci, pathogens that 
colonize the skin of diabetic patients are the causative agents of acute 
infections in antibiotic-naive patients, and are nearly always the cause of 
cellulitis in non-ulcerated skin. 
   Staphylococcus aureus is the most commonly recovered pathogen in 
most infections in which a single agent is isolated. Polymicrobial cultures, with 
an average of five or six organisms are often obtained from patients with 
chronic lesions  especially when they have been treated with antibiotics for 
sometime, anerobes, mostly Bacteroides Sp. and various anaerobic gram-
positive cocci are often isolated from deep necroses.  
Proteus Spp. and Escherichia coli predominate among gram-negative 
bacilli and Pseudomonas is often  isolated from indurated, wet wounds. 
In severe infections, Gram-negative pathogens and anaerobes 
predominate versus gram positive pathogens and Enterobacteriaceae, which are 
usually isolated from mild infections. Severity of infection does not predict the 
causative organism. 
Non limb threatening infections are usually caused by gram positive 
cocci, typically Staphylococcus aureus and Streptococcus spp.  In hospitalized 
patients with diabetic foot infections, methicillin–resistant Staphylococcus 
aureus as well as Enterococci are more prevalent. 
3.5.1.5 NECROTIZING FASCITIS: is a progressive rapidly spreading 
infection located in the superficial and deep fascial planes with secondary 
 
 
 
necrosis of the subcutaneous tissues. Due to the presence of gas forming 
organisms, subcutaneous air is often noticed in X-ray. The speed of spread is 
directly proportional to the thickness of the subcutaneous layer. Necrotizing 
fascitis moves along the deep fascial plane, therefore requiring rapid 
treatments. 
3.5.1.6 Fungal Infections 
Fungal infections develop as a result of poor foot hygiene, 
hyperhydrosis and accumulation of moist debris in the webs. Interdigital Tinea 
pedis is the most common form of chronic fungal foot infection. Itching, 
Redness, scaling, erosion and soaking of the skin with fluid usually occur, 
while in the late phase the redness subsides. Trichophyton metagrophytes, 
Trichophyton rubrum or Epidermophyton floccosum may be found.  
3.5.1.7 BONE INFECTIONS – OSTEOMYELITIS 
All patients with deep or long-standing ulcers should be evaluated for 
osteomyelitis. The possibility of an ulcer being complicated by osteomyelitis 
increases when the diameter of the ulcer exceeds 2cms and the depth in greater 
than 3mm, the possibility of complications becomes even higher when the 
white blood cell count, the erythrocyte sedimentation rate and the c-reactive 
protein levels are high. When a chronic recurrent perforating ulcer is neglected 
for a longtime, the bacteria invade the base of the lesion, then the fascial plane, 
later the periosteum leading to osteomyelitis13. 
 
 
 
3.5.2 ULCERS 
Ulcers – Another pattern of clinical presentation  in Diabetic foot lesions 
and it is often associated with infection. 
Diabetic Ulcers  are classified as  
a. Neuropathic ulcers 
b. Ischemic ulcers  
c. Neuro ischemic ulcers 
3.5.2.1 NEUROPATHIC ULCERS 
• Develop at areas of high plantar pressures.  (Metatarsal heads, plantar 
aspect of the great toe, heel or over bony prominences in a charcot – 
type foot). Neuropathy is present in about 85-90% of  foot ulcers in 
diabetic patients.  
• Are painless, unless they are complicated by infection. 
• There is callus formation at the borders of the ulcer. Its base is red, with 
a healthy granular appearance. 
• On examination evidence of peripheral neuropathy (hypoesthesia or 
complete loss of sensation of light touch, pain, temperature and 
vibration, absence of  Achilles tendon reflexes, abnormal vibration 
perception threshold, often above 25v, atrophy of the small muscles of 
the feet, dry skin and distended dorsal foot veins) is present. However 
 
 
 
the pattern of sensory loss may vary considerably from patient to 
patient. 
• The foot has normal temperature or may be warm. Peripheral pulses are 
present and the ankle brachial pressure index is (N) or above 1.3. 
3.5.2.2 ISCHEMIC ULCERS: 
• Ischemia is a major factor in 38-52% of cases of foot ulcers. These 
ulcers develop on the borders or the dorsal aspect of the feet and toes or 
between toes. They are usually painful. 
• There is usually redness at the borders of  the ulcer. Its base is yellowish 
or necrotic (black). There is history of intermittent claudication. 
• On examination signs of peripheral vascular disease (skin is cool, pale 
or cyanosed, shiny and thin, with loss of hair and onychodystrophy; 
peripheral pulses are absent or weak, the ankle – brachial index is  <0.9) 
are present. 
• Non-invasive vascular testing (duplex or triplex ultrasound examination, 
segmental pressures measurement, plethysmography) and angiography 
confirm peripheral  vasculopathy. 
3.5.2.3 Neuro-Ischemic Ulcers (Mixed Etiology ulcers) 
• Neuro ischemic ulcers have a mixed etiology ie., neuropathy and 
ischemia. 
 
 
 
3.5.3 GANGRENE 
Gangrene implies death with putrefaction of macroscopic portions of the 
tissue. 
3.5.3.1 Gangrene of Toes 
This is by far the most commonly noted type of lesion often starts from 
an unnoticed minor injury. It is usually of the wet type when there is infection 
but dry type of gangrene is also seen especially when there is associated 
vascular disease. 
3.5.3.2 Gangrenous Patches 
These occur in the pressure areas of the foot, most commonly over the 
heel, the 1st metatarsal medially and the base of the 5th metatarsal laterally. 
Small areas of gangrene are also seen in non pressure areas due to 
atheromatous debris. They are also seen in the interdigital clefts which are 
often missed during a routine examination. 
3.5.3.3 Diabetic Gangrene 
 This is a term specifically given to a gangrene of a fully vascularized 
foot. It is usually rapid on onset, painless with large areas of necrosis.There 
may be associated systemic illnesses, signs of deep infection are present but the 
striking feature is that the ankle pulses will be well felt. 
 
 
 
3.5.4 JOINT LESIONS 
Charcot Osteoarthropathy (Neuro-Osteoarthropathy, Charcot 
arthropathy, Diabetic Neuropathic osteoarthropathy) (DNOAP) 
 This represents one of the most serious complications of diabetes. It’s 
prevalence is between 1 & 7.5%, bilateral involvement has been reported to 
occur in 6-40% of patients in several series15. The development of this 
complication depends on peripheral somatic and autonomic neuropathy, 
together with adequate blood supply to the foot.  Mean age of presentation is 
approximately 60 years and the majority of the patients have diabetes of more 
than 15 years duration. Men & women are affected equally. 
3.6 PATHOPHYSIOLOGY OF DIABETIC FOOT LESIONS 
 Ischemia, neuropathy, infection and sustained hyperglycemia are the 
principal pathogenic factors. 
3.6.1 Role of Vasculopathy 
 Atherosclerosis tends to occur with greater frequency and severity and 
appears earlier in diabetics than in age - matched controls.  
Diabetics characteristically have two different types of arterial changes : 
Large vessel (macroangiopathy) and small vessel (microangiopathy). There are 
qualitative differences in mucopolysaccharides, calcium and cholesterol 
compared with non - diabetics. The macrovascular lesion in "Garden - Variety" 
atherosclerosis. The disease is much more extensive and more commonly 
associated with medial calcific sclerosis in diabetics than in non – diabetics16.  
 
 
 
Diabetic microangiopathy involves arteries smaller than 115 micrometer 
in diameter. The severity and extent of the small vessel lesion distinguish 
diabetics from non diabetics.  The hall mark of diabetic microangiopathy is 
PAS positive thickening of the capillary wall. 
DIABETIC PERIPHERAL VASCULAR DISEASE HAS 
PREDILECTION FOR TIBIO- PERONEAL VESSELS. ALL THE 
TIBIAL ARTERIES ARE OCCLUDED WITH SPARING OF THE 
DORSAL PEDAL OR COMMON PLANTAR ARTERY17. 
3.6.2 ROLE OF NEUROPATHY 
 Neuropathy is an important factor in the development of diabetic foot 
problems. Peripheral neuropathy may well be related to the quality of glycemic 
control. Hyaline arteriosclerosis has been found in intraneural arterioles in 
diabetics. 
Of the various manifestations of diabetic neuropathy, three are of 
relevance to the lower limb (i) the acute sensory; (ii) chronic sensorimotor and 
autonomic neuropathies. A progressive, stock and glove symmetrical loss of 
vibration, temperature and pain perception is typical of the chronic 
sensorimotor form of the disease18. 
The neuropathic diabetic foot is at greater risk as there is no protective 
sensation, minor trauma is unnoticed until there is significant ulceration, 
infection or bone injury. And also because of intrinsic foot muscle atrophy and 
secondary foot deformities, there is an alteration in the weight distribution and 
biomechanics of foot function that leads to pressure points, callus formation 
and skin breakdown. 
 
 
 
3.6.3 Other Risk factors 
Other pathogenic factors include hyperlipidemia, hypertension, 
smoking, the secondary consequences of hyperglycemia, obesity, genetic 
factors and hypercoagulability19. Diabetic foot complications depends on both 
the duration and severity of hyperglycemia over years. Foot deformities such as 
pesplanus, pescavus, bunionette, clawtoe, over riding toe deformity, mallet toe 
are more common in diabetics due to muscle atrophy and limited joint 
mobility20,21. 
Apart from the above obvious clinical predisposing risk factors, recent 
studies have revealed that very complex mechanisms are involved at the tissue 
- molecular level, which prevent normal healing processes. Many chemo - 
cytokines are involved, including matrix metalloproteinases, serine proteinases, 
integrins, chemokines, replicative cell senescence, growth factors and adult 
stem cells22. 
 Diabetic patients with tissue injury initially display impairment in the 
immune system response with reduced chemotactic effects to recruit 
inflammatory cells into the damaged tissues, thus, slowing down healing and 
increasing the risk of bacterial infection. Following this initial period, when the 
inflammatory response is eventually established, the process switches to an 
exacerbation of inflammation and proteolysis. The result of prolonged exposure 
to hyperglycemia also generates glycation of proteins and disturbances of cell 
responses, thus, further hindering the process of fibrosis and tissue repair23. 
Recent molecular studies on chronic diabetic ulcers indicated that more specific 
processes may be involved. For example, it has been found that leucocytes are 
prevented from ready entry and accumulation in the ulcers, which therefore, 
fail to achieve normal healing24.Other studies on the specific properties of 
fibroblasts from patients with chronic diabetic ulcers showed that these cells 
 
 
 
were different from those taken from patients without chronic ulcers in that the 
high molecular weight hyaluronic acid in the pericellular matrix was much 
more concentrated. The unique property of the fibroblasts might predispose 
these patients to chronic ulcer formation25.  
Clinical Pathways leadings to foot ulceration26. 
 
 
 
 
Diabetes Melitus
Neuropathy Peripheralvascular Disease
Sensory AutonomicMotor
Intrinsic 
Muscle 
Wasting
Decreased
pain &
Position
sensation
Decreased
sweat
production
Ischemia
Av shunting
Foot
deformity 
Motor
dysfunction
Dry skin
fissures callus
Charcot joint
disease
Limited Joint
Mobility
High Plantar foot
pressures
Trauma 
Foot
ulceration 
 
 
 
Table. 1.Risk factors for foot ulceration and infection 
Risk factor Mechanism of Injury or Impairment 
Peripheral motor  neuropathy Abnormal foot anatomy and biomechanics, 
with clawing of toes, high arch and 
subluxed metatarsophalangeal joints, 
leading to excess pressure, callus formation 
and  ulcers. 
Peripheral sensory neuropathy Lack of protective sensation, leading to 
unattended minor injuries caused by excess 
pressure or mechanical or thermal injury. 
Peripheral autonomic 
neuropathy 
Deficient sweating leading to dry, cracking 
skin. 
Neuro-osteoarthropathic 
deformities (ie, charcot 
disease) or limited joint 
mobility 
Abnormal anatomy and biomechanics, 
leading to excess pressure, especially in the 
midplantar area. 
Vascular insufficiency Impaired tissue viability, wound healing 
and delivery of neutrophils. 
Hyperglycemia and other 
metabolic derangements 
Impaired immunological (especially 
neutrophil) function and wound healing and 
excess collagen cross - linking. 
Patient disabilities Reduced vision, limited mobility and 
previous amputation(s). 
Maladaptive patient 
behaviours 
Inadequate adherence to precautionary 
measures and foot inspection and hygiene 
procedures, poor compliance with medical 
care, inappropriate activities, excessive, 
weight bearing and poor foot wear. 
Health care system failures Inadequate patient education and 
monitoring of glycemic control and foot 
care. 
 
 
 
 
 
3.7  EVALUATION OF DIABETIC FOOT LESIONS: 
3.7.1 Evaluation of Neuropathy: 
Loss of protective sensations is almost always found in diabetic 
ulceration. Neuropathy may be detected by following methods27 : 
* Vibration sensitivity : Tested by Biothesiometer and Tuning fork test 
* Temperature discrimination : tested by Tip Therm. 
Biothesiometer (Vibration Perception threshold meter) 
 This is a hand - held probe whose tip vibrates at 100 HZ. The voltage 
supplied to the probe can be adjusted from 0 to 50V. The probe is placed 
against the skin and voltage increased till the patient perceives the vibration. 
Mean of three readings is used to determine the vibration perception threshold 
for each foot. Normal readings should be less than or equal to 25v. 
 Semmes - Weinstein monofilament : is a valuable, easy to use tool. The 
monofilament is a long nylon wire, the tip of which is pressed against the skin 
to the point of buckling for at least one second. The points of testing are plantar 
aspects of 1st, 3rd and 5th digits, the plantar aspects of 1st, 3rd and 5th 
metatarsal heads, plantar midfoot medially and dorsally and the plantar heel (10 
sites totally). Neuropathy is said to exist when 4 out of there 10 sites show 
absence of sensation when the wire is pressed against the skin. Temperature 
discrimination can be tested economically and reproducibly with the tip therm. 
With a combination of the tuning fork test, the monofilament test and the 
temperature discrimination, the neurological risk status of each diabetic can 
therefore be determined rapidly and cheaply. 
 
 
 
3.7.2 Evaluation of Peripheral Vasculature: 
 This includes palpation of the pulses. (Dorsalis pedis, posterior tibial; 
popliteal and femoral) Absence of distal pulses in a diabetic foot is a sure sign 
of significant arterial disease. However, presence of palpable pulses does not 
absolutely exclude vascular disease. 
  Determination of Ankle brachial index using Doppler is a simple 
method of assessing vascular insufficiency. It is obtained by dividing the ankle 
systolic pressure by the brachial systolic pressure. Normal values are 1.0 ± 0.1. 
However, the ABI can be deceptive because calcification of vessels in Diabetes 
can lead to falsely elevated ABI28. 
3.7.2.1 Duplex Ultrasound 
This assesses both anatomical and functional abnormality in the various 
arterial segments. Significant stenosis is indicated by a peak systolic velocity 
ratio greater than two across the arterial lesion. Waveform analysis can give 
additional information about the degree of stenosis. 
3.7.2.2 Transcutaneous oxygen pressure mapping 
This can be used to determine the severity of foot ischemia, thus aiding 
selection of appropriate treatment. Studies show that if transmetatarsal TcPo2 
level is 30 mmHg or greater, treatment should be conservative comprising local 
wound care, debridement, or a minor ablative procedure. If the transmetatarsal 
TcPo2 level is below 30 mmHg, it will anticipate the need for vascular 
reconstruction. 
 
 
 
 
 
 
3.7.2.3 Angiography 
 Angiography  remains the `gold standard' for assessment of the lower 
arterial system prior to any intervention. In can be performed via femoral or 
brachial catheterisation with iodine - based contrast used to visualise the blood 
vessels. 
3.7.2.4 Magnetic resonance angiography 
This is likely to be the future investigation of choice. It can detect the 
occlusion distances. Diabetic patients with poor renal function may benefit 
from MRA. Studies show that MRA is better than digital subtraction 
angiography in revealing peripheral run off vessels and patent pedal vessels 
and suitable for distal by pass grafting. 
3.7.2.5 Co2 angiography 
 Also exhibits marked advantages over the procedures currently used 
through its non - allergising method and the absence of renal toxicity. 
3.7.3 Evaluation of Bone Involvement: 
Several methods are used for the diagnosis of osteomyelitis. 
 Plain radiographs have a sensitivity of 55%, but when repeated usually 2 
weeks later - the sensitivity is higher, making this the most cost effective 
diagnostic procedure. 
 Computerised tomography may reveal areas with subtle abnormalities 
such as periosteal reactions, small cortex erosions and soft tissue abnormalities. 
 
 
 
Magnetic resonance imaging has a sensitivity of almost 100% and a specificity 
of over 80% and has the potential to reveal abscesses. Therefore this is the 
preferred method for the diagnosis of osteomyelitis in many centers in cases 
where the plain radiographs do not provide sufficient information to make a 
conclusive diagnosis29. However, the specificity of MRI decreases in the 
presence of neuro - osteoarthropathy, prior bone biopsy, recent bone fracture or 
recent surgery.  Magnification radiography is also a very useful method for the 
detection of early osteomyelitis and it is used to follow up the disease. 
 99Tc scintigraphy is useful in cases of questionable osteomyelitis. It has 
a high sensitivity (over 90%) but a low specificity (33%) particularly in the 
presence of neuro - osteoarthropathy. Although, increased radionuclide uptake 
during the flow and pool phase is not specific to the diagnosis of osteomyelitis 
(it may mean soft tissue, bone infection or both), delayed images of the 99Tc 
scintigraphy showed increased blood flow to the bones only, thus increasing 
the specificity of the method in the diagnosis of bone infection. Patients with 
neuro - osteoarthropathy have increased bone blood flow in the absence of 
osteomyelitis. Like 99Tc scintigraphy, Gallium - 67 citrate accumulates in both 
osteomyelitis and neuro - osteoarthropathy. This is the reason for its low 
specificity in the diagnosis of osteomyelitis in diabetic patients. Indium 111 
White Blood Cell imaging (111In WBCs) is expensive, time consuming, has 
poor spatial resolution and does not distinguish soft tissue from bone 
infection30. 
3.8  MANAGEMENT OF DIABETIC FOOT LESIONS 
 In 1999, the American Diabetes Association recognised several basic 
principles of diabetic wound healing. 
 
 
 
 i. Off - loading 
 ii. Debridement 
 iii. Use of appropriate dressings 
 iv. Medical and surgical treatment of infection 
v. Vascular reconstruction and / or amputation or reconstructive 
foot surgery when necessary. 
3.8.1 Off loading or pressure relief devices 
As has already been mentioned, biomechanical changes are a frequent 
consequence of diabetic neuropathy resulting in an altered pressure load on the 
sole of the foot. Therefore consistent pressure relief is an essential precondition 
for the prevention and healing of foot ulcers31. 
 Total contact casting (TLC) is the most effective method of off - 
loading. A total contact cast in a special cast designed to redistribute the 
patient's weight off the ulcer site allowing ambulation while the ulcer is 
healing32. 
3.8.1.2 Off loading Techniques33 
Accomodative dressings - Patellar tendon - bearing braces 
Assistive devices  - Removable walking braces 
Callus removal  - Scotch cast boot 
Foot Casts   - Shoe cutouts 
Half, wedge or surgical shoes- Surgical correction of deformity 
Orthoses   - Therapeutic shoes 
Padded hosiery  - Total contact casting 
 
 
 
 
 
 
3.8.2 Debridement 
 Debridement of an ulcer is the corner stone of the management of active, 
acute or chronic wounds. The aim of debridement is to remove fibrin (white, 
yellow or green tissue seen on the bed of an ulcer) and necrotic tissue (black 
tissue) and to produce a clean, well vascularised wound bed. 
Types of debridement are as follows :- 
3.8.2.1 Sharp surgical (using scalpels) the gold standard for wound 
preparation, removes both necrotic tissue and micro-organisms. Majority 
of diabetics have neuropathy hence, feel no pain, therefore extensive 
sharp debridement or even operations on the feet can be performed 
without anesthesia. 
3.8.2.2 Mechanical using wet -to-dry dressings, hydrotherapy, wound irrigation 
and dextranomers. 
3.8.2.3 Enzymatic (using chemical enzymes such as collagenase, papain or 
trypsin in a cream or ointment base) - chronic wounds are enzymatically 
debrided in elderly patients when regular, sharp debridement is not            
possible, e.g. if the necrotic zone is thin, in ulcers with sinuses; and as 
an additional procedure to sharp debridement. 
3.8.2.4 Autolytic debridement; using invivo enzymes which self - digest 
devitalized tissue such as hydrocolloids, hydrogels, and transparent 
films. This uses the body's own enzyme and moisture to re-hydrate, 
soften and finally liquefy hard eschar and slough. It is selective, as only 
the necrotic tissue is liquified and painless to the patient. Its main 
indication is non - infected ulcers with mild to moderate exudates. 
 
 
 
3.8.2.5 Biomechanical wound Treatment : (Biosurgery) 
 Treatment with sterile maggots (Larval therapy). 
 The mechanism of action by which the larvae of Lucillia serricata 
(Greenhottle fly) contribute to the cleaning and healing of necrotically coated 
or infected wounds has yet to be fully elucidated34. The production of an 
antibiotic - like agent (also effective against micro - organisms resistant to 
conventional antibiotics), the presence of growth factors in the larval secretion, 
the destruction of bacteria by absorption and change in the pH value of the 
wound are postulated. 
Leeches (Hirudo medicinalis) are also used in amputation surgery. 
Because of their local anti - inflammatory and antithrombotic effect due to the 
formation of hirudin, they are used in areas of critically impaired circulation or 
in the development of hematoma. 
 After debridement and infection control, the raw area is allowed to heal 
by (i) Granulation, (ii) Applying Split skin graft or Local random flaps or 
Pedicled muscle flaps. 
3.8.3 Dressings: Broad spectrum of wound dressing materials currently are 
available.  
 
 
 
 
 
 
Table 2. Advantages and disadvantages of available types of dressings 
Type of dressing Advantages Disadvantages 
Traditional 
dressings (gauze 
and absorbent 
cellulose) 
Cheap and widely available. 
Appropriate for gangrenous 
lesions 
Adhere to the wound bed and may 
cause bleeding on removal. Provide 
little protection against bacterial 
contamination 
Films Semi-permeable. Form bacterial 
barrier. Durable. Require 
changing every 4-5 days. Cheap 
Useful on flat or superficial wounds 
only. Some patients are allergic to 
the adhesive in the dressing 
Foams Appropriate for ulcers with 
high production of exudates. 
Provide thermal insulation. 
Easily conformable, may be 
used to fill cavities without 
sinus tracts 
Effect difficult to quantify. Not as 
effective and rapid as surgical 
debridement. Not appropriate for 
neuro - ischemic ulcers, which 
produce minimal exudates. Wound 
must be monitored closely for signs 
of infection. 
Hydrocolloids 
 
 
 
 
 
Alginates 
 
 
Enzymatic 
Dresssings 
 
 
Medicated 
Dressings 
Safe and selective, using the 
body's own defense 
mechanisms. Good for necrotic 
lesions, with light to moderate 
exudates. May be used to fill 
cavities wihout sinus tracts. Can 
be easily used with a shoe. 
Adhesive surface prevents 
slippage. Do not require daily 
dressing changes. Cost – 
effective 
Useful as absorbents of 
exudates.Good for infected 
ulcers. Some products have 
hemostatic properties. 
 
Good for any wound with a 
large amount of necrotic debris, 
and for eschar formation. 
Promote autolysis and fast 
healing. Decrease maceration of 
the skin and risk of infection. 
 
 
Their occlusive and opaque nature 
prevents daily observation of the 
wound. Wound must be monitored 
closely for signs of infection. May 
promote anaerobic growth and mask 
a secondary infection. 
 
 
Not appropriate for neuro-ischemic 
ulcers,which produce minimal 
exudates. May dry out and form plug 
within the wound bed. Requires 
painstaking removal with the use of 
large amounts of saline. 
Costly. Must be applied carefully 
only to the necrotic tissue. May 
require a specific secondary 
dressing. Irritation and discomfort 
may occur. 
 
Data based on animal models and 
cell cultures only. 
 
 
 
3.9 SURGICAL MANAGEMENT OF DIABETIC FOOT 
• Surgical Decompression of foot and leg35b 
• Role of Amputation 
• Role of Vascular Management. 
3.9.1 SURGICAL DECOMPRESSION – 3 types. 
3.9.1.1 FOREFOOT DECOMPRESSION  
 Webspace infection, central plantar space infection are the indications. 
Incision should be placed deep into plantar space cutting plantar aponeurosis. 
3.9.1.2 PLANTAR SPACE DECOMPRESSION 
 Main indication is a plantar space infection. Characteristic factor of this 
abscess is disappearance of longitudinal arch and skin crease.The area of 
longitudinal arch may bulge,  sole is edematous. Incision is made from little toe 
to the heel over the medial aspect. 
3.9.1.3 FOOT AND LEG DECOMPRESSION(Fasciotomy) 
Vertical incision for leg and horizontal for foot abscess, cellulitis are 
done. 
AVERAGE HEALING TIME 
 Forefoot decompression   = 11 - 38 days 
 Plantar decompression  = 12 - 40 days 
 Foot and leg decompression = 12 - 60 days 
 
 
 
3.9.2 ROLE OF AMPUTATION 
Factors deciding amputation are35c: 
 1. Age 
 2. Nephropathy 
 3. Major vessel disease 
           4. Gross neuropathy 
            5. Presence of gangrene 
 6.        Involvement of bone 
 7. Uncontrolled Diabetic KetoAcidosis 
 8. Septicemia  
3.9.2.1 Toe amputation 
Patients with demonstrably good circulation are selected for these 
procedures, indicated when there is gangrene of one digit in the absence of rest 
pain or when there is a perforating ulcer over the interphalangeal joint of great 
toe. 
3.9.2.2 Great toe amputation  
 Incision made around base of the toe, extended 2 - 3 cms proximally 
along medial border of the foot. Tendons and tissues are divided and toe 
dysarticulated through  Metatarsophalangeal joint. 
3.9.2.3 Other toes amputation 
 Incision at the junction of living and dead tissue. Carefully strip the soft 
tissues from bone and divide the bone through base of proximal phalanx or 
dysarticulate at Metatarsophalangeal joint. 
 
 
 
3.9.2.4 Ray Amputation 
 Remove the entire toe and the distal half of the metatarsal shaft. 
Provides excellent drainage of deep parts of foot and removes prominent 
metatarsal head beneath an ulcer. Indicated for infection involving single 
Metatarsophalangeal joint arising from trophic ulcer and or infection in deep 
flexor tendon sheath.  
 Incision encircles base of toe and extends proximally into the sole. The 
toe dysarticulated at Metatarsophalangeal joint. The distal part of plantar 
incision extended down. The metatarsal shaft is shaved  off its soft tissue 
attachment. Bone is divided approximately middle of metatarsal bone. This 
provides good drainage. 
3.9.2.5 Trans Metatarsal amputation 
 For gangrene involving more than one toe and for persistent or recurrent 
plantar ulcer. Incision is made across the dorsum of foot at the level of middle 
of metatarsal bone. The plantar incision is at the base of toes. Both are joined 
along medial and lateral borders. 
3.9.2.6 Below knee amputation 
 Indicated when gangrene and uncontrolled sepsis involves whole foot or 
lower 1/3 of leg. The posterior flap in lower leg amputation should be long. 
The bone is divided in the midleg at the junction of upper and middle 1/3 rd of 
leg. Anterior surface of tibia is bevelled and fibula divided 3 or 4 cms higher 
than tibia.  
 
 
 
3.9.2.7 HIGHER LEVEL AMPUTATIONS 
 1. Through knee dysarticulation 
 2. Above knee amputation . 
3.10 VASCULAR MANAGEMENT: 
3.10.1 Role of pentoxyphylline 
 A xanthine derivative, decreases blood viscosity and increases red cell 
flexibility, there by increasing blood flow to microcirculation and  enhancing 
tissue oxygenation. 
3.10.2 Antiplatelet Drugs 
 Platelet aggregation inhibitors like aspirin and dipyridamole decrease 
progression of atherosclerosis. 
Patients who require Emergency Vascular Management. 
 1. Acute embolic manifestation presenting an cold feet. 
2. Acute or chronic occlusion arterial disease presenting with skin 
discoloration, cellulitis and blebs. 
3. Extensive edema necessitates decompression  
 Revascularisation procedures intervention (dilation) and reconstructive 
(by pass surgery procedures), should be employed as supplementary measures 
to preserve the extremity in diabetic foot syndrome. 
3.10.3 Endovascular management 
 Balloon angioplasty with or without stent placement is used for in flow 
vessel and femoro–popliteral and distal popliteal lesions. The outcome depends 
 
 
 
on the site, length, morphology of the lesion and the state of the distal run - off 
vessels. Currently stents are metallic and permanent and may be self - 
expanding or require balloon expansion. However, complications may risk 
losing the entire vessel and associated run - off. At present, there is no clear 
evidence in the literature to support routine distal balloon angioplasty36. 
3.10.4 Reconstructive procedures 
 Because of the particular anatomy (the tibial vessels are frequently 
affected while the ankle and foot arteries are spared), crural (by pass to lower 
leg vessel) or pedal (by pass to foot arteries) by pass procedures have 
increasingly obviated the need for amputation in diabetics over the past few 
years37.  
 The favoured graft material is long saphenous vein but arm vein can also 
be used. In the absence of vein, prosthesis can be used. 
3.11 ADJUVANT THERAPY FOR WOUND HEALING 
                     All the below listed therapies are under experimental studies. 
3.11.1 Cultured Human Dermis and cultivated equivablents. 
 Cultured human dermis consists of neonatal dermal fibroblasts cultured 
in vitro into a bio-absorbable mesh to produce a living, metabolically active 
tissue containing (N) dermal matrix proteins and cytokines38. The effectiveness 
of these as a treatment for diabetic foot ulcers is also being examined 
(Dermagraft; Graft skin). 
 
 
 
3.11.2 Hyperbaric oxygen therapy 
 Hyperbaric oxygen (HBO) involves immersing the wound in a pure O2 
atmosphere, either with steady or cyclically raised pressure, in a leg chamber or 
by placing the whole patient in a chamber. A number of possible mechanisms 
form the rationale for this treatment including improved O2 supply promoting 
the proliferation of granulation tissue and antibacterial effect on anaerobic 
organisms39. 
3.11.3 Ketanserin  is a 5HT2 serotonergic receptor antagonist reported to 
inhibit platelet aggregation, block vasoconstriction, improve tissue 
perfusion and increase granulation tissue formation. It can be 
administratured orally or topically. 
3.11.4 Growth factors Growth factors are applied directly to the wound 
surface with the intention of stimulating cellular movement, replication 
and matrix synthesis leading to healing in chronic non - healing wounds, 
rhPDGF is a recombinant platelet derived growth factor40. rbFGF is a 
recombinant basic fibroblast growth factor using Escherichial colitype B 
and RGDpm is an ariginine - glycine - aspartic acid peptide matrix41. 
3.11.5 Granulocyte - colony stimulating factor (G-CSF) 
 G-CSF increases both the production and release of neutrophils from the 
bone marrow enhancing the ability to fight infection in the blood. While people 
with diabetes are not neutropenic, diabetes represents an immunocompromised 
state secondary to neutrophil dysfunction, it is hypothesised that improved 
neutrophil production and function will improve bactericidal activity in foot 
ulcers42. 
 
 
 
3.11.6 Electrical Stimulation 
Electric current has been shown to facilitate wound healing in animal 
models and improve blood flow to the foot in vascular studies in diabetic 
patients. 
3.11.7 Sulodexide is an antithrombotic drug being tried for peripheral 
occlusive arterial disease. 
3.11.8 Hyaff : is a semi synthetic ester of hyaluronic acid. Serum or wound 
exudates when in contact with Hyaff form a moist environment which 
promotes granulation and healing. 
3.12 Tertiary prevention of the diabetic foot syndrome 
 Patients with diabetic foot syndrome remain at extremely high risk 
patients for foot complications throughout their life43. Health education must 
include information about what to do in the event of an injury or impending 
amputation in addition to preventive foot care aspects. Regular after care in 
special institutions considerably reduces the risk of recurrence of lesions and 
subsequent amputation in these patients. Numerous studies in the past two 
years have shown that more than 50% of all amputations in diabetics are 
avoidable if the following procedures are applied systematically. 
- Regular inspection of feet and foot wear of diabetics at each visit 
to the doctor. 
- Preventive foot care and shoe provision in high risk patients and 
additional education. 
- Use of multifactorial and multidisciplinary treatment concepts in 
the case of foot lesions. 
 
 
 
- Early diagnosis and appropriate treatment of peripheral 
circulatory disorders in diabetics. 
            - On going after care of patients with previous foot ulcerations or      
prior amputations. 
- Strict adherence to defined indications for amputation and 
establishment of amputation registers.  
3.12.1 General objectives of rehabilitation 
1. Increase range of motion, strength, endurance  
2. Maximise safety of lower extremity 
3. Pain relief 
4. Independent ambulation  
5. Health education 
3.12.2 Temporary measures for ambulation 
 1. Walker 
 2. Axillary crutches 
3.12.3 Permanent measures for ambulation 
 1. Below knee prosthesis 
 2. Above knee prosthesis44  
3.12.4. Appropriate foot care includes45 
 i. Care of callus, removal of corns, care of interdigital spaces 
 ii. Treatment of fissures, macerations and fungal diseases 
 iii. Nail care and the careful correction of nail deformities. 
 
 
 
iv. Avoid temperature extremes, test water with elbow before 
bathing. 
v. If the feet feel cold during night wear socks. Do not apply hot 
water bottes or heating pads. 
vi. Do not walk on hot surfaces 
vii. Do not walk bare footed 
viii. Do not use chemical agents to remove corns and calluses. Do not 
use strong antiseptic solutions. 
ix. Do not use adhesive tape on the feet. 
x. Inspect the inside of shoes daily for foreign objects, nail points, 
linings and rough objects. 
xi. Do not soak feet. 
xii. For dry feet use a thin coat of lubricating oil.  
xiii. Wear properly fitting stockings, change stockings daily. 
xiv. Shoes should be comfortable at the time of purchase. They should 
be made of leather. 
xv. Do not wear shoes without socks. 
xvi. Do not wear sandals with throng between the toes. 
           xvii. Cut nails straight across. 
xviii. Avoid crossing the legs as this can compress the nerves and 
vessels. 
xix. See the physician regularly to be sure that the feet is examined at 
each visit. 
xx. Notify your physician at once if you develop a blister or a sore. 
 
 
 
3.13. IDEAL DIABETIC FOOT TEAM 
Diabetic foot requires a team work to save the foot46. The team consists 
of : 
 1. General Surgeon 
 2. Dietician 
 3. Podiatrist 
 4. General physician 
 5. Microbiologist 
 6. Radiologist 
 7. Pharmacist 
 8. Nurse 
            9. Orthopaedician 
10. Vascular surgeon 
11. Plastic surgeon 
12. Physiotherapist 
13. Laboratory specialist (foot pressures) 
 
 
 
 
 
 
 
 
4.0. MATERIALS AND METHODS 
4.1 Materials:  
           This is a prospective study of consecutive Diabetic patients with foot 
complications admitted in the surgical wards of Government Royapettah 
Hospital during the period of August 2005 – August 2007. A total of 200 cases 
were analysed during this period. 
4.2 Methods: 
 Detailed history and thorough clinical examination was done in all 
cases. Documentation was done using a stratified proforma which included 
demographic data of the patients studied; all the details of investigations 
carried out and the types of management and treatments provided to the 
patients enrolled in the study. 
 For all patients, hematological, biochemical, microbiological and 
radiological investigations were carried out as enumerated in the proforma 
 
 
 
using standard procedures. Blood sugar and Renal parameters were performed 
at the time of admission. Fasting,  Post prandial, Pre dinner and Post dinner 
Blood sugar was done on the next day and repeated according to Blood sugar 
levels. Urine analysis including urine acetone was done . X-ray of local part, 
Ultrasonogram Abdomen and Hand held Doppler study of both limbs was 
done. As Duplex scan was not available in our hospital, they were done at 
Government General Hospital for patients who were suspected to have 
Arteriopathy. 
 Appropriate treatment was provided according to the Grade of Diabetic 
foot lesions. This included infection control with antibiotics only ; Slough 
excision with antibiotics ; slough excision with split skin graft or flap; 
fasciotomy; incision and drainage or amputation at appropriate level. All these 
procedures were carried out as described.35b,c  
Health Education was given to patients regarding foot care and were 
followed up regularly every 2 weeks. 
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5.0 RESULTS AND OBSERVATIONS 
5.1 Demographic Analysis: 
 A total of 200 patients with Diabetic foot lesions were admitted and 
treated during the study period August 2005 to August 2007. The clinical 
 
 
 
pattern of foot lesions, Investigations done, treatment given and the associated 
complications were analysed and the following results obtained. 
Table – 1 
Age & Sex Distribution 
Age Male % Female % Total % 
0-19 0 0 0 0 0 0 
20-29 1 0.5 0 0 1 0.5 
30-39 9 4.5 1 0.5 10 5 
40-49 27 13.5 15 7.5 42 21 
50-59 37 18.5 13 6.5 50 25 
60-69 34 17 27 13.5 61 30.5 
70-79 24 12 5 2.5 29 14.5 
80-89 6 4 1 0.5 7 3.5 
 138 69% 62 31% 200  
 
 Peak Incidence of diabetic foot was seen in the Age group of 50-
69years. Increased prevalence was seen among males (69%). In males 
increased prevalence was seen in the age group of 50-59 years and in females 
in age group of 60-69 years. 
 
 
 
Table – 2 
Socio Economic Level of the patients studied. 
 
Socio Economic Class No. of Patients % 
Poor Socio-Economic Status 
Monthly Income (< Rs.1000) 
110 55% 
Lower Middle Class 
(Monthly Income: Rs. 1000 – 6000) 
30 15% 
Upper Middle Class 
(Monthly Income> Rs.6000) 
60 30% 
 
 Greater prevalence of diabetic foot was observed in Poor Socio 
economic class since most of them were manual labourers prone to trauma and 
due to poor hygiene (p < 0.001). Prevalence is also higher in Upper middle 
class probably due to sedentary life style. 
Table – 3 
Duration of symptoms before admission 
Duration No. of Patients % 
< week 30 15 
7-14 days 50 25 
> 15 days 120 60 
 
 The above table shows that only less than 15% of patients reported to 
hospital within 1 week of onset of symptoms. Reasons attributed for delayed 
reporting for treatment are either that the symptoms were less severely felt by 
patients due to neuropathy or due to seeking native treatment or due to socio-
economic constraints 
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Table – 4 
Family History of Diabetes 
Family History of Diabetes No. of Patients % 
Present 135 67.5% 
Absent 65 32.5% 
 
 There was significant family history of diabetes mellites in 67.5% of 
patients(p < 0.0001). 
Table – 5 
Duration of Diabetes before the development of foot lesions . 
Duration No. of Patients % 
Detection at present admission 30 15 
< 5 yrs 93 46.5 
5-10 yrs 69 34.5 
10-15 yrs 7 3.5 
> 15 yrs 1 0.5 
 
 It is observed in this study that 81% of the foot lesions had occurred in 
patients who have had Diabetes mellitus for more than 1 year to 10 years. 
Table –6 
Precipitating Causes 
Duration No. of Patients % 
Spontaneous 60 30 
Trauma 140 70 
 
Foot lesions developed either due to trauma or spontaneously. But most 
of the neuropathic patients would have not noticed or felt the trauma. 
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Table – 7 
Foot wear use among Diabetic foot patients 
Percentage Foot wear 
60% Walk Bare foot 
35% 
5% 
Wear slippers or chappals 
Wear shoes 
 
60% of the patients reported to walk bare-footed belonged to poor socio 
economic class who had increased prevalence of Diabetic foot lesions. 
Table – 8 
Prevalence of Obesity 
Body Mass Index No. of Patients % 
Normal Range 36 18 
High BMI 104 52 
Lower BMI 60 30 
 
Most of patients  (52)% presenting with Diabetic foot lesions were obese 
having Body Mass Index higher than normal. 
5.2 Profile of Investigations: 
Table – 9 
Blood Sugar Values on Admission 
 
Random Blood Sugar level (mg/dl) No. of Patients % 
< 200 50 25 
201 – 300 105 52.5 
> 301 45 22.5 
 
The analysis showed that about 52.5% of patients had uncontrolled 
Random Blood Sugar levels on admission in the range of 201 – 300 mg/dl. 
 
 
 
Table – 10 
Range of  Blood Sugar Levels and number of patients in each group. 
 
Blood 
Sugar 
mg/dl 
Random 
blood 
sugar 
Fasting 
Blood 
sugar 
Postprand
ial blood 
sugar 
Pre 
Dinner 
blood 
sugar 
Post 
Dinner 
blood 
sugar 
< 150 1 1 - 3 - 
150-200 49 123 3 110 1 
201-250 70 43 43 67 39 
251-300 35 27 52 15 57 
301-350 42 6 83 4 84 
351- 400 3  17  15 
> 401 -  2  4 
 
 Random Blood Sugar was taken immediately after admission. Fasting, 
Post-Prandial, Pre dinner and Post dinner blood sugar was carried out on the 
next day of admission. Insulin dosage was adjusted accordingly to bring about 
diabetes control . After Glycemic control, Blood sugar was repeated once in 
three days. It was noticed that the Glycemic status determined the severity of 
infection. By achieving Glycemic control along with appropriate surgical 
management, infection was effectively controlled.  
Table – 11 
 
Presence of Ketoacidosis in patients presenting with Diabetic foot lesions 
 
Urine Ketones No. of Patients % 
Positive 43 21.5 
Negative 157 78.5 
 
About 21.5% of patients presenting with Diabetic foot lesions had 
Diabetic Ketoacidosis. Controlling infection was important in treating DKA in 
these patients. 
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Table – 12 
Prevalence of Anemia Hemoglobin level of 10gm was taken as index 
Anemia No. of Patients % 
Present 122 61% 
Absent 78 39% 
 
61% of patients with Diabetic foot lesions had anemia and these patients 
were given hematinics and Blood transfusion. This enhanced wound healing in 
them. 
Table – 13 
Assessment of Renal Parameters 
Renal Parameters No. of Patients % 
Elevated 70 35 
Normal 130 65 
 
About 35% of patients had elevated Renal parameters. This was either 
due to dehydration or Associated Diabetic nephropathy. 
Table –14a 
Assessment of  Bacteriology in foot infections 
Microorganism Noted No. of Patients % 
Single Organism 80 73% 
Mixed Organism 20 18% 
No organizm isolated 10 9% 
 
About 110 patients presented with Diabetic foot ulcers with infection. 
Pus was sent for culture and sensitivity, of this 73% were of single organisms 
like Klebsiella, E.coli, Proteus,etc. Only 18% had mixed organism grown in 
culture. 
 
 
 
                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
56
40
18
2
68
0
10
20
30
40
50
60
70
N
o.
 o
f P
at
ie
nt
s
Systemic
hypertension
Ischemic Heart
Disease
Nephropathy Pulmonary
Tuberculosis
Retinopathy
Associated Diseases
PRESENCE OF OTHER MORBID CONDITIONS
ASSESSMENT OF BACTERIOLOGY IN FOOT INFECTIONS
73%
18%
9%
Single Organism Mixed Organism No organizm isolated
 
 
 
Table – 14b 
                               Assessment of  Micro organisms present 
 
Micro organism No. of Patients 
Escherichia coli 47 
Proteus 48 
Klebsiella 16 
Pseudomonas 11 
Staphylococci 8 
 
Escherichia coli and Proteus were the most common organisms isolated 
from the Diabetic foot ulcers. 
Table 15 
Antibiotic Sensitivity 
 
Antibiotics Sensitive in 
No. of Patients 
Gentamycin 82 
Ciprofloxacin 71 
Cefotaxime 96 
Ampicillin 40 
Cotrimoxazole 36 
Doxycycline 43 
 
Most patients were found to be sensitive to Ciprofloxacin, Gentamycin 
and Cefotaxime. 
5.3 Clinical Presentation and their Assessment: 
Table – 16 
Clinical Pattern of Presentation of Diabetic foot lesions 
 
Presentation No. of Patients % 
Abscess 4 2 
Cellulitis 46 23 
Ulcer 110 55 
Gangrene 39 
Toe gangrene 36 
Foot gangrene 3 
19.5 
Joint involvement 1 0.5 
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This shows that about 55% of patients presented with foot ulcers and 
that toe gangrene was also a common presentation about 36% which if treated 
earlier can prevent higher level amputation. 
Table – 17 
Presentation of various Grades of Diabetic lesion 
(Based on Wagner's Classification) 
Grade No. of Patients 
0 - 
1 - 
2 94 
3 20 
4 36 
5 3 
 
Most of the patients presented with Wagner Grade II type of foot 
lesions. Hence early and effective management can save the limb. 
Table – 18 
Clinical Assessment of Arteriopathy 
Peripheral Pulses No. of Cases % 
Absent 16 8 
Present 184 92 
 
The above table shows that 8% of patients had macrovascular 
arteriopathy. These patients were subjected to Duplex  Scan. As the facilities 
for Revascularisation was not available in our Hospital, Six patients were 
having peripheral arterial disease were referred to Vascular Surgery 
department, Government General Hospital, Chennai for Angioplasty and 
Revascularisation procedures for limb salvage. 
 
 
 
Table – 19 
Prevalence of Neuropathy 
Neuropathy No. of Cases % 
Present 61 30.5 
Absent 139 69.5 
 
Neuropathy was present in 30.5% of patients presenting with diabetic 
foot lesions. Patients with Neuropathy presented with Higher Grades of 
Diabetic foot lesions. 
                                                       Table  20 
                               Assessment of retinopathy 
Retinopathy No. of Cases % 
Present 96 48 
Absent 104 52 
 
Retinopathy of various grades was present in 96% of patients and this is 
a risk factor for diabetic foot complications as they are more prone to trauma 
due to impaired vision. 
Table – 21 
Assessment of Bone Involvement 
No. of Patients subjected to 
x-ray local part 
Bone Involvement % 
200 30 15 
 
 
 
 
15% of patients with diabetic foot lesions had bone involvement either 
in the form of osteomyelitis, pathological fracture, small joint dislocation or 
other bony changes. 
Table – 22 
Prevalence of bony deformities 
Bony deformities No. of Cases % 
Present 78 39 
Absent 122 61 
 
Anatomical Bony deformities was present in 39% of patients which are 
again an important risk factor for diabetic foot complications. 
                                         Table – 23 
               Prevalence of Risk factors in Diabetic patients. 
Risk factor Present in No. of Cases % 
Family H/o Diabetes  135 67.5 
Bony deformities 78 39 
Obesity 104 52 
Arteriopathy 16 8 
Neuropathy 61 30.5 
Retinopathy 96 48 
 
Majority of the patients had either one or more of the risk factors leading 
to complications in Diabetic foot infections. 
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Table – 24 
Presence of other Morbid Conditions 
Associated Diseases No. of Cases 
Systemic hypertension 56 
Ischemic Heart Disease 40 
Nephropathy 18 
Pulmonary Tuberculosis 2 
Retinopathy 68 
 
Presence of other systemic complication in patients with Diabetic foot 
lesions increases the morbidity. 
5.4 Management of Diabetic foot lesions of the study:   
Table – 25 
Management Strategies of Diabetic foot lesions 
Management Strategies No. of cases 
Antibiotics Only 24 
Incision and Drainage 4 
Fasciotomy 19 
Slough Excision 102 
Slough Excision with SSG 22 
Slough Excision with flap 2 
Toe Dysarticulation 22 
Ray Amputation 3 
Forefoot Amputation 3 
Below knee Amputation 6 
Above Knee Amputation 1 
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Either a single modality or combined modality of treatment was given 
for effective management. Antibiotics was given to all these patients. Slough 
excision was done in stages. 
Table –26 
Insulin Requirements 
SIU/day No. of Cases 
0-10 7 
11-20 23 
21-30 70 
31-40 96 
> 40 4 
 
 Majority of patients required about 21-40 units of Insulin per day. 
Insulin was given both in plain & monotard form. Dosage was adjusted 
according to blood sugar levels and thrice daily doses of Insulin was given. 
Table – 27 
Duration of Hospitalisation 
Duration of Stay No. of Days 
Average 27 
Maximum Duration 168 
Minimum 6 
 
The average number of days of hospitalization was 27. Maximum 
duration was 168 days complete recovery was seen in 93.5%  of patients either 
after slough excision, disarticulation or Amputation. 
 
 
 
13 cases expired or went home against Medical advice or got absconded 
in the middle of treatment. 
Success rate was about 93.5% and mortality rate of 2.5%(5patients) was 
encountered in our study .Outcome was not traceable in the remaining 4% of 
patients. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.0 DISCUSSION 
6.1 Prevalence of Diabetic foot: 
The incidence of Diabetes Mellitus is increasing globally. India is 
emerging as the epicenter of Diabetes today with the current prevalence rate of 
14% in the population. Patients with Diabetes have a 12-25% lifetime risk of 
developing a foot ulcer. Foot ulcers have become a major and increasing public 
health problem; the morbidities, impairment of the quality of life of patients 
and the implied costs for management have attracted the attention of health 
policy providers. Inspite of their rising importance, the management provided 
for foot ulcers is often inadequate, resulting in delayed healing and eventually 
the possibilities of amputation. It is projected that developing countries will 
experience the greatest rise in the prevalence of Type 2 Diabetes in the next 
twenty years. The people living in these countries, therefore, could expect 
greater risks of foot ulceration47. 
The present study was conducted in Government Royapettah Hospital in 
Chennai. In our study of 200 consecutive cases of Diabetic foot, maximum rate 
of 30.5% was seen in 60-69 years age group, while it was 25% and 21% in the 
50-59 and 40-49 years age-groups respectively. The age groups involved in our 
present study is similar to that reported from Karl Franzens University, 
Austria(Mean age 66 years) and by Hasbum et al from Mexico Hospital48 
(Mean age 60+/-4 years). A study was undertaken in the USA in 2004 through 
 
 
 
the 2002 National Hospital Discharge Survey, looking at 275,000 in patient 
records from 500 hospitals since 1996. The study revealed that elderly 
Diabetics had twice the risk of developing a foot ulcer, three times the risk of 
developing a foot abscess and four times the risk of developing 
Osteomyelitis49. 
6.2 Causes of diabetic foot: 
In our present study, the most common cause of Diabetic foot was 
trauma in 70% and the remaining as complications of their Diabetic status. In 
Nigeria, the available hospital studies have variously suggested that trauma or 
complications of traditional bonesetting and complications from Diabetes 
Mellitus are the most common causes50. It is also observed in our study that 
60% of Diabetic foot occurred among those who walked bare foot and 35% in 
those wearing only slippers or chappals while only 5% prevalence was 
observed in those wearing shoes. This observation revealed that prone-ness to 
injuries increased the risk of developing Diabetic foot lesions(P<0.001) 
6.2.1 Diabetic Foot Lesions: 
In Wagner’s Grade 2 through 5, the overall chance of local or major 
amputation is estimated to be around 60%. In the present study, the patients 
with diabetic foot presented with abscess(2%); cellulitis(23%); ulcer(55%) and 
gangrene(20%). The ulcer pattern ranged from 94% in Grade 2, 20% in Grade 
3, 36% in Grade 4 and 3% in Grade 5 category. In earlier studies, Treece et el 
from City Hospital,50 UK in their study of 389 diabetic ulcer patients, 78.4% 
were of Grade 2 type, 10.8% had Grade 3 type and rest Grade 4. Austria 
reported 22.7% of cases with Grade 2 type and 38.7% with Grade 3 type. 
 
 
 
Similarly Hasbum et al from Mexico Hospital48 have also reported 23% of their 
diabetic cases with Grade 2 ulcers and 21% with Grade 3. Our study 
observations are similar to those of Treece et al and Hasbum et al. 
 
 
 
6.2.2 Infections: 
Infected chronic ulcers may be classified as mild, moderate and severe. 
Appropriate tissue and bone cultures are useful to guide the use of antibiotic 
therapy. Gram positive organisms account for the majority of infections, while 
the prevalence of Methicillin resistant Staphylococcus aureus has become 
prevalent in recent years. Unachukukwu et al have stated that although gram 
positive organisms are overwhelming in chronic diabetic ulcers, the 
polymicrobial nature of bacterial growth should not be ignored in the 
management planning, especially in developing countries51. 
The pattern of infection as observed in the present study reveals that 
while 73% of cases were infected with single infection of gram positive 
organism, 18% of cases had polymicrobial infections. Among these 
Escherichia coli and Proteus were the predominant micro organisms involved. 
Chronic ulcers are frequently co-existing with fungal infections of the 
foot and it has been said that bacterial infection could be predisposed by fungal 
infection. Lee et al in 2003 from Korea in a study of 13,271 patients with 
diabetes have shown that 78.4% have fungal infection of the feet. Among these 
infections, 70.8% are Tinea pedis type52. The investigators, therefore, consider 
fungal infection a risk factor for foot ulcers. 
6.3 Management of Diabetic foot:  
           The general management and treatment of Diabetic foot ulcers is 
multidisplinary. Foot ulceration is a complication caused by diabetes and is 
invariably infected .The Diabetic state, therefore, needs to be well controlled 
 
 
 
and infection should be effectively treated. Hence Infection control with 
appropriate antibiotics becomes a priority. Ulcer care and ulcer surgery is to be 
considered depending upon the clinical situation and the status of diabetic 
control. 
Although a multitude of factors affect the healing of chronic diabetic 
foot ulcers, daily or more frequent cleaning and dressing are essential 
requirements. Regular daily bathing in saline or dilute antiseptic solution offers 
a better chance of cleaning the ulcers, compared with dressing alone. There are 
changing perspectives in the local management of Diabetic ulcers which 
include, apart from new dressings, skin substitutes, growth factors and stem 
cells. 
Despite much efforts towards the treatment of Diabetic foot ulcers, the 
incidence of lower extremity amputation rate remains about the same. 
Amputation is a costly outcome and should be prevented as far as possible until 
otherwise unavoidable. 
Amputation of the toe(s) with non healing ulcers or gangrene can 
sometimes be the only solution towards limb salvage. Amputation, sacrificing 
the whole leg, is a life-saving procedure for large, unhealed ulcers which are 
usually accompanied by other complications of neuropathy and ischemia. 
Patients on the whole would prefer to retain the limb and the attending medical 
team should be supportive of limb salvage, if feasible. 
In the hospital settings, the incidence of amputations, whether minor or 
major, tends to be higher because of the need for Hospital admission when the 
 
 
 
ulcer reaches a more advanced state. The statistics from one General  Hospital 
in Hong Kong indicated that in a ten year period from 1995 to 2005, 154 of the 
851 patients admitted with diabetic foot ulcers underwent major lower limb 
amputations(18.1). In the present study of 200 patients, toe dysarticulation was 
needed in 22(11%). The types of amputation resorted to were Ray amputation 
Forefoot amputation in 3 cases each, below knee amputation in 6 and Above 
knee amputation in 1 case. Majority of the cases could be managed by limb 
salvage through debridement program of slough excision(102 cases) and 
slough excision with SSG (in 22 cases), slough excision with flap was resorted 
in two cases and fasciotomy in 19 cases. Compared to our experience, 
Hasbeem et al from Mexico Hospital reported amputation performed in 45% of 
their 377 patients series. Similarly Abhas et al from Tanzania53 has resorted to 
amputations in 45% of their 288 cases managed in the Muhimbili National 
Hospital. However a lower rate of 2.4% amputation was reported by Jeffcoate 
et al from UK, City Hospital among the 370 patients treated by them which is 
similar to our observations. Similar amputation rate of 4.9% was also reported 
by Treece et al from UK, City Hospital50 in another series of 389 patients. 
6.4 Limb Salvage Programme: 
Thus it emerges that limb salvage programme in diabetic ulcers with 
early debridement might significantly reduce the need for amputations of some 
extent. However prevention of ulcer formation need to be given priority in 
Diabetic foot management. Consideration of social and psychological 
implications are also important in planning strategies for prevention of ulcer 
recurrences. Since the Diabetic foot ulcer has developed into a public health 
problem, it deserves a holistic approach including socio-economic planning and 
rehabilitation. 
 
 
 
 
7.0. SUMMARY AND CONCLUSIONS 
7.1 Summary: 
200 consecutive Diabetic patients with foot complications admitted in 
Government Royapettah Hospital, Chennai during August 2005 to August 2007 
where characterized for demographic factors, investigatory profiles, clinical 
presentations as per International norms; and underlying risk factors. Effective 
management strategies were planned and executed with the sole aim of 
achieving diabetes control and salvaging the diabetic foot with significant 
success. 
7.2 Conclusions: 
7.2.1). 76.5% of the diabetic foot cases were in the 40 – 69 years age 
groups, while maximum cases in men was seen in 50 – 59 years age group and 
the same in women was in the 60 – 69 years age group. 
7.2.2). 55% of the diabetic foot patients were poor and 60% were 
walking bare-footed  and hence prone for trauma and ulcer development. 
7.2.3). 52.5% of the cases had high blood sugar levels of 201 – 300 
mg/dl at the time of admission and 21.5% had Keto-acidosis. 
7.2.4). 91% of the patients were bacteriologically positive for infection 
either with single organism(73%) or with multiple organisms(18%). 
7.2.5). The patients with diabetic foot presented with abscess(2%); 
cellulitis(23%); ulcer(55%) and gangrene(20%).  While 110/200(55%) cases 
 
 
 
presented with diabetic ulcers, 85.4% of these cases presented with Grade II 
ulcers as per Wagner’s Classification. 
7.2.6). Anatomical Bony deformities, arteriopathy, neuropathy, 
retinopathy, obesity were the common risk factors in the study group leading to 
complications in diabetic foot. 
7.2.7). In this study, 165/200(82.5%) could be limb-salvaged with 
antibiotics alone and/or slough excision in various stages and fasciotomy. 
7.2.8). 35 cases(17.5%) have to undergo different levels of amputation 
within which majority of them(22/35) were only toe Disarticulation. 
7.2.9). The present study concludes that adequate glycemic control, 
appropriate antibiotic therapy and prompt slough excision–mediated 
debridement therapy can be the successful limb salvage programme in nearly 
93.5% of the diabetic foot cases. 
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Annexure 
 
 
CLINICAL  PROFORMA 
 
 
 
 
Name :    Age :  Sex :   IP No : 
 
DOA :    DOD :   Duration of Stay : 
 
Presentation  : Ulcer  [    ] Ulcer with Infection [    ] 
 
   Deep Ulcer [    ] Deep ulcer with tendon 
       involvement [    ] 
 
   Bony involvement [    ] Gangrene [    ] 
 
   Cellulitis  [    ] 
 
Site of foot ulcer :  Great toe Ball [    ] Other toe [    ] 
   Heel   [    ] Dorsum [    ] 
   Metatarsal head [    ] Ankle  [    ] 
   Others   [    ] 
 
Duration of ulcer <7 days [    ] 7 - 14 days  [    ] 
at admission  >15 days [    ] 
 
H/o. Injury : Yes [    ] No [    ] 
 
Systemic symptoms on admission : Yes [    ] No [    ] 
 
Diabetic Status 
 
Newly detected 
 
0-5years [   ] 5-10years [   ] 10-15 years  [   ] >15years [   ]  
 
Treatment for diabetes : Regular  [    ]  Irregular [    ] 
 
Treatment : Sulfonyl urea [   ] Biguanides  [   ] 
   Combination  [   ] Insulin  [   ] 
   Insulin + OHA [   ] 
Smoking History : Yes ( )    No( ) 
 
Alcoholism : Yes [    ] No [    ] 
Nature of work : Manual  [    ]   Sedentary [    ] 
 
 
 
 
Other concomitant 
 Illness : HT [    ] IHD [    ] PT [    ] 
   Nephropathy [    ] Retinopathy [    ] 
 
Drug History : B-Blocker  [    ] Calcium channel blocker[    ] 
             ACE inhibitor [    ] Others   [    ] 
 
Place of living : Urban [    ] SemiUrban [    ] Rural [    ] 
 
Knowledge about diabetic 
 foot problems Aware [    ] Ignorant [    ] 
 
Source of knowledge : Massmedia  [    ] Doctor[    ] 
     Nurse  [    ]  
Other health worker [    ] 
 
Nature of foot wear used : Nil [    ] Any type [    ] 
 
H/o. Diabetes in family: Yes [    ] No [    ]   
 
H/o. Diabetic foot problem  
 in family :  Yes [    ] No [    ]   
 
Past history of amputations 
 for foot problems :  Yes [    ] No [    ]   
 
Anthropometry : 
 
Body Wt. in Kgs : Ht :  BMI :  Wt / Ht2 
Blood pressure: 
General examination: 
Local examination of the foot lesion: Ulcer size, extent, edge,depth, base. 
Evidence of peripheral vascular disease :           Yes    (  )     No  (  ) 
 
Dorsalis pedis Artery Palpable     :                       Yes [    ] No [    ] 
                                                                     Impaired [    ] 
 
 
 
 
Posterior tibial Artery palpable         :              Yes [    ] No [    ] 
                                                                     Impaired [    ] 
             
 Popliteal Artery palpable   :                                  Yes     [    ]    No   [   ] 
                                                                                Impaired  [   ] 
 
 Femoral Artery palpable    :                                  Yes     [    ]    No   [   ] 
                                                                                Impaired  [   ] 
Ankle brachial index _______________________ 
 
Evidence neuropathy 
a. Proprioception : Yes [    ] No [    ]   
     Impaired [    ] 
 
b. Vibration sensation : Yes [    ] No [    ]   
     Impaired [    ] 
 
c. Two point discrimination : Yes [    ] No [    ]   
                Impaired [    ] 
At Admission laboratory profile : 
 
 Blood Sugar – Fasting, Post prandial, Predinner and Postdinner 
 Serum Cholesterol 
TGL   LDL 
HD L   VLDL 
 Hb % 
Evidence of azotemia : Yes [    ] No [    ]   
 Albuminuria   : Yes [    ] No [    ]  
Urine Sugar              :          Yes     [    ]    No      [    ] 
           Urine Acetone          :          Yes     [    ]    No      [    ]  
In infected ulcer - organisms isolated 
 a.__________________ b. ________________ 
 
Sensitive antibiotic on admission  
 a. ___________________ b. __________________ 
 c. ___________________ d. __________________ 
 
 
 
 
 
Resistance noted with  
 a. ___________________ b. __________________ 
 c. ___________________ d. __________________ 
Results of doppler study 
 Dorsalis pedis            _________________ 
 Posterior tibial  _________________ 
            Popliteal                             _________________ 
            Femoral                              _________________ 
Evidence of microangiopathy - Retinopathy 
 
 Yes [    ] No [    ] 
 
Grade of retinopathy 
 N [    ] GrI [    ] Gr II [    ] GrIII [    ]  Gr.IV [    ] 
 
Chest Xray 
Electro-cardiogram 
Echocardiogram 
Treatment details and complications. 
 
Oral Hypoglycemics or Insulin 
Daily dose of insulin needed for diabetic control. 
 
 <10 Units [    ] 10-12units [    ] 20-30units [    ] 
 30 - 40 units [    ] >40 units [    ] 
Anti Platelet Drug: 
Treatment required :  
                                  Antibiotics only  [  ]  
                                  Dressing [    ] 
   Debridement [    ] 
   SSG [    ] 
                                  Flap    [    ] 
   Toe amputation  [    ] 
   Transmetatarsal  [    ] 
   Bk amputation [    ] 
   AK amputation 
 
Outcome of Treatment modalities: 
 
 
 
 
KEY TO MASTER CHART 
 
DOS   : Duration of stay 
SES  :  Socioeconomic status 
P      :  Poor 
L      : Lower Middle Class 
M    : Upper Middle Class 
BMI   : Body Mass Index 
FOD   : Family H/O Diabetes 
Dur.DM  : Duration of Diabetes Mellitus 
FBS   : Fasting Blood Sugar 
BD   : Bony Deformities 
N     : Neuropathy 
V     : Vasculopathy 
B      : Bone Involvement 
DKA   : Diabetic KetoAcidosis 
      R.    : Retinopathy 
      A     : Anemia 
      Micro  : Microbiology 
      Antibiotic  : Antibiotic Sensitivity 
      Gr   : Grade( Based on Wagner’s Classification) 
      R    : Right 
      L    : Left 
      #    : Fracture 
      Ps    : Pseudomonas 
      St    : Staphylococci 
      K    : Klebsiella 
      Ec    : Escherichia coli 
      Pr    : Proteus 
      Cf    : Cefotaxime 
      Cp   : Crystalline Penicillin 
      G    : Garamycin 
      A    : Ampillicin 
      D    : Doxycycline 
      S    : Co-trimoxazole 
S.No Name Age DOS SES BMI FOD Dur. FBS BD N V B DKA R. A Micro Antibiotic Lesion Management
/Sex DM
1 Dhanalaxmi 60 F 46 P < + 10 200 + + - - - + + Ps G,Cp,Cf GrII Ulcer L foot Slough Excision
815398
2 Nijamudeen 70 M 36 L N + 5 210 - + - - - - + k Cp,Cf GrII Ulcer R foot Slough Excision
815427
3 Elumalai 70 M 48 P < + 6 290 - - + + + + + Gangrene L foot Transmetatarsal
816123 toes Gr IV amputation
4 Saraswathy 55 F 50 P > + New 320 + + - - - - + Cellulitis R leg Antibiotics
816898
5 Pushpa 45 F 53 P > + 2 180 + + - - + + - Cellulitis L leg Antibiotics
817000
6 Srinivasan 57 M 22 L > + New 280 + - - - - + + Cellulitis L leg Fasciotomy
817898
7 Kullamma 75 F 39 P < + 15 150 + - - - - + + Ec,Pr G,Cp,Cf GrII Ulcer L foot Slough Excision
817999
8 Indirani 60 F 37 U > + 5 120 - - - - - + - Ec,Pr G,Cp,Cf GrII Ulcer R foot Slough Excision
818484
9 Natarajan 59 M 41 P N + 8 250 + - - + + + + Gangrene II toe Toe Dysarticulation
818500 L  Gr IV
10 Sundaram 50 M 19 L N + 2 290 - - - - + - - St D,Cf,G,A Abscess R foot Slough Excision with 
818848 Gr III SSG
11 Sakunthala 40 F 39 U > + New 200 - - - - - + + Pr G,Cp,D GrII Ulcer R foot Slough Excision
818900
12 Bakiyam 72 F 49 P > + 2 180 + + - - - - + Pr G,S,Cf GrII Ulcer L foot Slough Excision
819148
13 Pattammal 40 F 39 U > + 5 320 - + - - + + + Ec Cp,D,S,G GrII Ulcer R foot Slough Excision
819340
14 Gangadaran 85 M 9 P > + 15 280 + + + + + + + Gangrene R Emergency BK 
819351 foot Gr V Amputation
15 Krishnan 65 M 22 P > + 5 180 - - - - - + + Ps G,Cp,Cf GrII Ulcer R foot Slough Excision
819336
16 Saroja 70 F 32 P < + 10 300 + + - - + + + St D,Cf,G,A Abscess R foot Incision & Drainage
819292 Gr III
17 Sakunthala 70 F 35 P > + 8 180 - - - - - + + Ec G,D,Cp GrII Ulcer L foot Slough Excision
819756
18 Devandran 80 M 34 P < - 8 150 + + - + - + + Ps Cf,D,Cp,G GrII Ulcer L foot Slough Excision
819801
19 Sankariah 60 M 8 P > + 6 210 - + - - - - + K Cf,Cp GrIII Ulcer L foot       AMA
819874
20 Thomas 55 M 10 U > + 5 280 + - - - + - - Gangrene II toe R Second Toe 
820628 R Gr IV Dysarticulation
21 Srinivasan 55 M 12 U > + New 310 - - - - - - + Ec,Pr Cf,Cp,G GrII Ulcer R foot Slough Excision
820720
22 Raniammal 61 F 19 P > - 6 200 - - - - - + + Cellulitis L leg Antibiotics
820687
23 Murugan 29 M 15 U > + 4 180 - + - - - - - Cellulitis R leg Antibiotics
820969
24 Perumal 70 M 59 P < - 10 210 + + - - + + - Pr Cf,G GrII Ulcer R Slough Excision
816030 forefoot
25 Alamelu 64 M 17 U > + 8 200 + - - - - + - Ec Cp,D,S,G GrIII Ulcer R Slough Excision
821557 foot
26 Komalavathi 60 F 14 P < + 5 250 + - - + - + - IV,V Toe IV,V toe 
Gangrene R Dysarticulation
27 Velludai 40 F 11 U > + New 300 - + - - + - + Cellulitis L foot Antibiotics
822352
28 Nagappan 45 M 18 U > + New 270 - - - + - - + K Cf,Cp,S,G GrIII Ulcer R Slough Excision & 
822304 foot SSG
29 Saroja 50 F 6 P < + New 320 - - - - - - + Ec Cp,D,S,G GrII Ulcer R foot Slough Excision  
823551
30 Velammal 61 F 15 P > - 6 200 - - - - - + - Cellulitis R leg Antibiotics
823552
31 Ponurangan 67 M 8 P > + 5 180 - + - - - + + Pr Cf,G GrII Ulcer L foot Slough Excision
823969
32 Vinayagam 70 M 14 P < - 10 180 - + - - - + - Ec,Pr Cp,D,S,G GrII Ulcer R foot Slough Excision
824100
33 Duraikannu 45 M 15 U > + New 300 + - - + + - - R IV toe IV toe Dysarticulation
824548 Gangrene
34 Indrani 60 F Abs P > + 8 210 - - + + - + - St D,Cf,G,A GrIII Ulcer L foot Slough Excision
824548
35 Ramar 57 M 49 P < + 5 180 - + - - + - + K Cf,Cp GrII Ulcer R foot Slough Excision & 
824789 SSG
36 Elizabeth 65 F 49 P > + 10 220 + + - - - + + Gangrene R R Great toe
824809 Great toe Dysarticulation
37 Chellammal 60 F 7 U > - New 320 - + - - - - + Ec G,Cp,S,Cf GrII Ulcer R foot Slough Excision 
825486
38 Arumugam 58 M 20 U > + 7 240 - - - - + - - Cellulitis L leg Fasciotomy
825952
39 Raghunath 68 M 15 P < - 5 250 + + - + + + - R III & IV toe R III & IV toe
827325 Gangrene Dysarticulation
40 Rajammal 50 F 20 U > + New 300 - - - - - - + Pr G,Cf GrII Ulcer L foot Slough Excision
828339
41 Kailasam 48 M 23 U > + 3 210 + - - + - - + R III toe R III toe
828383 Gangrene Dysarticulation
42 Saradha 60 F 19 P < - 5 200 - + - + - + + Pr G,Cf GrIII Ulcer L Slough Excision & 
829330 foot SSG
43 Ranganathan70 M 17 P < + 8 180 - + - - - + + Ec,Pr G,Cp,D,S GrII Ulcer R foot Slough Excision 
829180
44 Sundaram 70 M 13 P < - 5 250 + + - + + + - L Great toe L Great toe
830138 Gangrene Dysarticulation
45 Valliammal 55 F 18 P < + New 280 - - - - - - + Cellulitis R leg Fasciotomy
830530
46 Murugammal 45 F 16 U > + New 300 - - - - - - + Cellulitis L leg Fasciotomy
830716
47 Krishnan 57 M 30 U > + 5 200 - - - - - - + Cellulitis L leg Antibiotics
830979
48 Mohd.Beevi 75 F AMA P > - 10 180 - + - - + + + Cellulitis R leg Antibiotics
831032
49 Muthulaxmi 60 F 80 P > + 8 350 + + - + + - + St G,D,Cf,A GrIII Ulcer R leg Slough Excision
832142
50 Parasuraman59 M 32 P > + 4 250 - - - - - - + R II toe R II toe Dysarticulation
833306 Gangrene GrIV
51 Sugavanam 50 M 13 U > + 4 230 - - - - - - + Cellulitis R leg Antibiotics
833727
52 Vasantha 40 F 18 U > + 5 250 - + + + + - + Ec G,Cp,D,S GrIII Ulcer R leg Slough Excision
833946
53 Ponamma 72 F 46 P < - 15 180 - - - - - + + k Cf,Cp GrII Ulcer L foot Slough Excision
832166
54 Lakshmi 40 F 18 U > + New 280 - + - - + - + Ec,Pr Cp,Cf,G GrII Ulcer R foot Slough Excision
835863
55 Munusamy 60 M 13 P > + 8 150 - - - - - + - Pr Cf,G GrII Ulcer R foot Slough Excision
836165
56 Narayanan 70 M 13 P < - 10 200 - - - - - + + Ec Cf,Cp,G GrII Ulcer R foot Slough Excision
836262
57 Veerasamy 75 M 19 P < - 10 200 - - - - - + + Ec Cf,G,Cp,S GrII Ulcer L foot Slough Excision
836241
58 Radha 55 M 12 P < + 6 250 - - - - + - - Pr Cf,G GrII Ulcer R foot Expired
836236
59 Syed Amir 55 M 12 P > + 5 180 - - - - - - - Pr Cf,G GrII Ulcer R foot Slough Excision & 
837282 SSG
60 Ellamma 48 F 13 U > + 3 200 - - - - - - - Ec Cf,Cp,S,G GrII Ulcer R foot Slough Excision
837336
61 Diilibabu 48 M 40 U > + 3 210 + + - + + - + Ps Cf,D,Cp,G GrIII Ulcer L foot Slough Excision
833461
62 Laxmi 75 F 56 P < - 10 150 - + - - - + + St G,D,A,Cf GrII Ulcer R foot Slough Excision
837991
63 Kutty 75 M 28 P N - 10 150 - + - - - + + Pr G,A,D,B GrII Ulcer R foot Slough Excision
838020
64 Kasim 40 M 23 U > + 2 200 - - - - - - - Ec,Pr G,D,S,Cf GrII Ulcer R foot Slough Excision
838416
65 Radha 50 F 19 U > + 6 210 + - - - - - + R forefoot R Transmetatarsal
838553 Gangrene GrIV Amputation
66 AbdulKhadar 55 M 19 U > + New 300 - - - - - - + K Cf,G,Cp GrII Ulcer R foot Slough Excision
839743
67 Annamalai 55 M 20 P < + 2 210 - - - - - - + Pr Cf,G GrII Ulcer L foot Slough Excision
840306
68 Mani 61 M 25 P < - 6 180 - - - - - + - Ec G,D,S GrII Ulcer R foot Slough Excision
840443
69 Veerasamy 70 M 25 P N - 10 190 - + - - + + - Ec G,Cp,D,S GrII Ulcer R foot Slough Excision
841101
70 Shanthi 47 F 14 U > + 7 200 + + - - - - - Pr Cf,D,G GrII Ulcer R foot Slough Excision
841793
71 Ganesan 56 M 28 P < + 5 150 - - - - - - + Ec G,Cp,Cf GrII Ulcer R foot Slough Excision &
843632 SSG
72 Vasu 50 M 86 P > + 3 150 + - + + - + + St D,A,G GrIII Ulcer L leg Left Above knee
844484 Amputation
73 Saraswathi 60 F 33 P < - 5 150 - - - - - + + Ec,Pr Cf,G GrII Ulcer R foot Slough Excision &
844849 SSG
74 Kannan 61 M 8 P N 0 6 160 - - - - - + + Cellulitis R leg Antibiotics
845281
75 Jayaraman 80 M 14 P < - 10 180 - - - - - + - Ec Cp,D,S,G GrII Ulcer L foot Slough Excision
845950
76 Kannan 48 M 17 U > + New 280 - - - - + - + Cellulitis L leg Fasciotomy
846604
77 Muskim 52 M 23 U > + New 250 - + - - - - + Pr Cf,G,D GrII Ulcer R foot Slough Excision
846572
78 Marimuthu 30 M 13 U > + 1 200 - - - - - - + Pr Cf,G,A,D GrII Ulcer L foot Slough Excision
847112
79 Valliammal 50 F 11 U > - 5 180 - - - - - - + Pr Cf,G,S,D GrII Ulcer L foot Slough Excision
847711
80 Mercy 60 F 17 P > - 3 150 - + - - - + + Ec,Pr Cf,G,Cp GrII Ulcer L foot Slough Excision
868884
81 Arumugham 60 M 13 P < - 2 180 - - - - - + - Cellulitis L leg Antibiotics
848366
82 Ganesan 45 M 9 U > + New 210 - - - - - - - Cellulitis L leg Antibiotics
850991
83 Krishnaveni 65 F 10 P > - 5 150 - - - - + + - Cellulitis L leg Fasciotomy
852248
84 Thillaiamma 60 F 19 P > + 4 180 - + - - - + + Ec Cp,D,G,Cf GrII Ulcer R foot Slough Excision
849941
85 Chinnaponnu65 F 13 P N - 3 200 + - - - - + + Pr Cf,G,D,S GrII Ulcer R foot Slough Excision
850446
86 Ayyasamy 40 M 31 U > + New 220 - - - - - - + K Cf,Cp GrII Ulcer L foot Slough Excision & 
847742 SSG
87 Madhar 44 M 35 U > + 2 180 + - - + - - + Ps D,Cp,G GrIII Ulcer L foot Slough Excision 
848283
88 Kuppan 40 M 76 U > - New 250 + - + + + - + Gr V Ulcer R R BK Amputation
849746 leg with SSG
89 Mani 47 M 24 P N + 5 180 - - - - - - + Ec,Pr Cp,G,S,Cf GrII Ulcer L foot Slough Excision
850442
90 Sekar 52 M 12 P < + 7 200 - - - - - - + Cellulitis R leg Fasciotomy
850460
91 Afisuddin 51 M 35 P > + New 250 + - - - + - + Cellulitis L leg Fasciotomy
851086 with abscess
92 Kumar 52 M 35 P < + 8 200 - - - - - - + Ps Cf,D,Cp,G GrII Ulcer R Slough Excision &
851732 foot SSG
93 Mani 48 M 18 U > + 3 300 + + + - + - + Charcot joint L BK Amputation
852304 L foot
94 Kadirvel 59 M 14 P < - 6 180 - - - - - + + Ec G,D,S,Cf GrII Ulcer R Slough Excision
852417 foot
95 Kannan 67 M 14 P < - 4 200 - + - - - + - Cellulitis L leg Antibiotics
852922
96 Ramkrishnan56 M 16 U > + 2 190 - - - - - - - Pr Cf,G,A,D GrII Ulcer R foot Slough Excision
852622
97 Vasantha 65 F 11 P > - 8 210 + + - - - + + Pr Cf,G,A,D GrII Ulcer L foot Expired
853077 Septicemia
98 Killiammal 50 F 15 P > + 2 240 - - - - + - + Ec,Pr Cp,D,S,G GrII Ulcer L foot Slough Excision
852871
99 Murugan 45 M 34 U > + New 260 + - - + + - + Ps Cf,Cp,D,G GrIII Ulcer R Slough Excision
853293 foot
100 Chinnapaiya 60 M 41 P < - 10 180 - - - - - + + k Cf,Cp GrII Ulcer R Slough Excision & 
854090 foot SSG
101 Kumar 52 M 29 P < + 4 200 + - - - - - + Gangrene L L Great toe
854609 Great toe Dysarticulation
102 Meganathan 55 M 17 P < + 5 210 + + - - + - + K Cf,Cp,S GrIII Ulcer R Fasciotomy &
854688 foot SSG
103 Narasimhan 34 M 15 P < + 3 180 - - - + - - + L II toe gangreneL II toe Dysarticulation
855276
104 Dhandapani 52 M 6 U > + 4 150 - - - - - - + Cellulitis L leg Antibiotics
853308
105 Krishnan 65 M 14 P < - 10 180 - + - - - + + Cellulitis R leg Antibiotics
855346
106 Ramasamy 34 M 12 P < + New 200 - - - - - - + Cellulitis R leg Fasciotomy
855697
107 Subramani 50 M 14 U > + 6 180 - + + - - - - PVD L LL Referred to GGH
855666
108 Manickam 30 M 6 U > + New 210 - - - - - - - Cellulitis L leg Antibiotics
855882
109 Mani 79 M 35 P < - 15 300 + + - + + + - Gangrene L II L II toe Dysarticulation
855923 toe&ulcer L foot & Slough Excision
110 Govindan 66 M 11 L N - 10 180 - - - - - + - Cellulitis R leg Antibiotics
856306
111 Krishnan 60 M 13 P > - 8 200 - - - - - - + Cellulitis R leg Antibiotics
855875
112 Raju 40 M 15 U > + 2 280 + - - + + - + Abscess R Foot Incision & Drainage
857377
113 Kannan 46 M 13 U > + 5 170 - - - - - - + Ec Cp,D,S,Cf GrII Ulcer R & Slough Excision
857968 L foot
114 Chinnamani 52 M 12 P < + 4 180 + + + - - - + PVD R LL Referred to GGH
858012
115 Rani 45 F 12 L N + 3 200 - - - - - - + Cellulitis R leg Antibiotics
856149
116 Indrani 75 F 12 P < - 10 180 - + - - - + + Ec,Pr Cp,D,S,Cf GrII Ulcer L foot Slough Excision
865305
117 Karpagam 50 F 12 P < + 5 190 - - - - - - + Pr Cf,G,Cp,D GrII Ulcer R foot Slough Excision
859989
118 Kasthuri 43 F 16 U > + 3 180 - - - - + - + Cellulitis L leg Fasciotomy
858017
119 Mariammal 60 F 32 P > - 10 150 - + - - - + + k Cf,Cp,D,A GrII Ulcer R foot Slough Excision
859209
120 Karpagam 60 F 17 U > - 5 150 + - - - - + + Ec Cp,S,D,Cf GrII Ulcer L foot Slough Excision
859989
121 Ashokkumar 31 M 37 P < + New 240 - - - - - - + Cellulitis L leg Fasciotomy & SSG
858031
122 Ponnan 45 M 37 P < + 1 200 - - - - - - + Ps Cf,Cp,D,G GrII Ulcer L foot Slough Excision &
858492 SSG
123 Magimairaj 47 M 36 P < + 6 220 - + - + - - + k Cf,Cp,A,D GrII Ulcer L foot L BK Amputation
858555
124 Durai 70 M 29 P > - 10 180 - - - - - + + Pr Cf,G,A,D GrII Ulcer L foot Slough Excision &
858926 SSG
125 Balasundar 48 M 7 U > + 3 200 + - + - - - + PVD L LL Referred to GGH
859001
126 Sivagnanam 50 M 15 P < + 4 150 - + - - - - + Ec Cp,D,S,Cf GrII Ulcer R foot Slough Excision
860231
127 Sampath 51 M 17 P < + 5 190 + - - - - - + Ec,Pr G,D,S,Cf GrII Ulcer R Rotation flap
860311 Great toe
128 Moideen 40 M 6 U > + New 250 - - - - - - + PVD R LL Referred to GGH
860712
129 Babu 66 M 6 L N - 8 180 - - - - - + + PVD Both LL Referred to GGH
861100
130 Anthony 39 M 6 L N + 13 180 - - - - - - + PVD R LL Referred to GGH
861206
131 Poorani 35 F 17 L N + New 210 + - - - - - - Cellulitis R leg Fasciotomy
861202
132 Samuthram 45 F 90 L N + 2 180 + - - + + - - Gangrene R R Great toe
865707 Great toe Dysarticulation
133 Mohanraj 38 M 23 L N + 1 150 + - - - - - - Cellulitis R leg Fasciotomy
861173
134 Pazhamalai 55 M 10 L N - 5 180 - - - - - + - Cellulitis L leg Fasciotomy
861526
135 Arumugham 60 M 55 U > - 6 270 + + - + + + + Intramuscular Fasciotomy &
861819 abscess L leg SSG
136 Ravikrishnan 72 M 26 P > - 10 180 - - - - - + - Pr Cf,G,A GrII Ulcer L foot Slough Excision
862307
137 Krishnan 48 M 9 L N + 2 200 + - - - - - - Abscess L foot Incision & Drainage
862710
138 Sheik Nabi 68 M 10 U > - 8 250 + + - + + + - Gangrene R Ray Amputation R
863539 Great toe Great toe
139 Palani 55 M 25 P < + 5 300 + - + - + - - Wet gangrene R BK Amputation
863769 R lower leg
140 Rangasamy 80 M 12 P > - 12 200 + - + - - + + Gangrene R R Midtarsal
864849 forefoot Amputation
141 Rukmani 70 F 11 P < - 10 200 + - + - - + - Gangrene R Ray Amputation R
862552 great & II toe great & II toe
142 Rahmanbi 63 F 17 U > - 8 150 - - - - - + - Ec,Pr Cp,G,S,Cf GrII Ulcer R foot Slough Excision & 
864066 Flap
143 Gangadevi 45 M Abs L N + 2 150 - - - - - - - k Cf,Cp,D,S GrII Ulcer L foot Slough Excision
864420
144 Sundaramal 65 F 14 P < - 8 200 + + - + + + - R Great toe R Great toe
864431 gangrene Dysarticulation
145 Babu 65 M 30 P < - 5 180 - - - - - + - Cellulitis R leg Antibiotics
865495
146 Padma 40 F Abs U > + New 210 + - - - - - - Ec,Pr G,Cf,Cp GrII Ulcer L foot Slough Excision
866176
147 Susai 55 M 7 L N - 5 210 + - + - - - - PVD R LL Referred to GGH
866471
148 Narasimhan 72 M 33 P < - 8 200 - - - - - + - Ec S,Cp,Cf,A GrII Ulcer R foot Slough Excision &
866504 SSG
149 Parmasivam 59 M 168 U > - 4 180 + - - - - + - Ps D,Cp,Cf,A GrII Ulcer L foot Slough Excision 
867675
150 Sudailai 60 M 165 P < - 5 260 + + - - - + - Wet Gangrene R Great toe
867932 R Great toe Dysarticulation
151 Murugesan 60 M 24 U > - 5 200 + - - - - + - Cellulitis R leg Fasciotomy
867900
152 Murthy 45 M 31 L N + 2 220 + - - + - - - R Great toe R Great toe
868108 Wet Gangrene Dysarticulation
153 Gangaiyan 50 M 11 U > + 4 210 + - - - + - - Wet Gangrene Ray Amputation R
868390 R Great & II toe Great & II toe
154 Beer Sahib 80 M 29 P < - 20 150 + + - - - + - Pr G,Cf,Cp,A GrII Ulcer L foot Slough Excision
874960
155 Vedachalam 60 M AMA P > - 10 240 - - - - - - - Ec,Pr S,Cp,Cf,A GrII Ulcer L foot Slough Excision
875117
156 Muniappan 55 M 56 U > + 5 200 - - - - - - - Cellulitis R leg Antibiotics
875190
157 Gunasagar 55 M 22 L N - 6 180 - - - - - - + k Cp,Cf,A GrII Ulcer R foot Slough Excision
875888
158 Annammal 61 F 34 P < + 6 180 + + - - + + + Cellulitis L leg Antibiotics
875956
159 Mani 30 M 34 L N + 1 210 + - - - - - - Gangrene R R IV toe 
876210 IV toe Dysarticulation
160 Subramani 70 M 28 P < - 8 160 - - - - - + - Ec,Pr S,Cp,Cf,A GrII Ulcer R foot Slough Excision
876300
161 Saroja 64 F 29 U > + 9 150 - - - - - + - Pr G,Cp,Cf,A GrII Ulcer L foot Slough Excision
876374
162 Subramani 85 M 28 L N + 15 300 + + + - + + - Gr V lesion R R BK Amputation
874011 foot
163 Arumugham 65 M 33 U > - 10 200 - - - - - + + Pr G,Cp,Cf,A GrII Ulcer R foot Slough Excision
874204
164 Radha 70 F 93 P > - 8 180 - - - - - + + St G,Cp,Cf,A GrII Ulcer L foot Slough Excision
874300
165 Raji 65 M 23 P > + 5 160 + - - - - + + Ec S,Cp,Cf,A GrII Ulcer L foot Slough Excision
874464
166 Unnamalai 70 F 28 U > - 10 170 - - - - - + + Pr Cp,Cf,A GrII Ulcer R foot Slough Excision
874506
167 Srinivasan 65 M 9 P < - 8 150 - - - - - + + Ec S,Cp,Cf,A GrII Ulcer L foot Slough Excision &
874949 SSG
168 Kasthuri 60 F 24 L N + 5 240 + - - - - + + R Great toe R Great toe 
868575 Gangrene Dysarticulation
169 Usman 63 M Abs P > - 3 180 - - - - - + + k Cp,Cf,A GrII Ulcer L foot Slough Excision
868974
170 Parthasarthy 65 M 96 P > - 5 160 + - - - - + + Ps D,Cp,Cf,A GrII Ulcer R foot Slough Excision
870037
171 Attukarar 70 M 95 P < - 12 170 - - - - - + + St Cp,Cf,A,G GrII Ulcer R leg Slough Excision &
870064 SSG
172 Srinivasan 59 M 17 L N + 8 200 + + - - - - + Gangrene L L Middle toe
870973 middle toe Dysarticulation
173 Kumar 60 M 29 P < + 10 180 + - - - - - + Ec S,Cp,Cf,A GrII Ulcer R leg Slough Excision 
871073
174 Hagadbasha 60 M Abs P > + 5 180 - - - - - + - Ec,Pr S,Cp,Cf,A GrII Ulcer R foot Slough Excision
871390
175 Truman 60 M 6 L N + 8 150 + + + - - + - PVD both LL Referred to GGH
871391
176 Kasthuri 57 F 18 P < + 7 180 - - - - - - - Ec S,Cp,Cf,A GrII Ulcer R foot Slough Excision
871078
177 Saradha 60 F 70 L N + 4 180 + + - - - + - k Cp,Cf,A GrII Ulcer L foot Slough Excision
871872
178 Thangavel 72  M 6 P < + 10 170 - - + - - + + PVD L LL Referred to GGH
872536
179 Thambidurai 45 M 30 U > + New 280 + - - - - - + Cellulitis L leg Fasciotomy
872757
180 Narasaiah 60 M 63 P < + 5 150 - - - - - + + Ec,Pr S,Cp,Cf,G GrII Ulcer L foot Slough Excision &
873317 SSG
181 Umar Sherif 34 M 18 U > + 1 190 - - - - - - - Pr G,Cp,Cf,A GrII Ulcer L foot Slough Excision &
873658 SSG
182 Lakshmi 40 F 26 U > + 2 210 + - - - - - - R IV & V toe R IV & V toe
876380 Gangrene Dysarticulation
183 Muthulaxmi 40 F 29 L N + New 270 + - - - - - - Cellulitis L foot Antibiotics
876396
184 Thambu 45 M 39 L N + 1 200 - - - - - - + Ec Cf,A,G GrII Ulcer R foot Slough Excision
876402
185 Basheer 65 M 23 U > + 5 190 + + - - - + + Cellulitis R leg Antibiotics
876444
186 Saraswathi 50 F 51 L N + 4 180 + - - - - - + Ps Cf,A,G GrII Ulcer R foot Slough Excision
876900
187 Jagadambal 61 F 49 P > + 9 180 - - - - - + - Ec Cf,A,G GrII Ulcer R foot Slough Excision
876940
188 Marumatham67 M 38 P > + 7 160 + + - - - + - Cellulitis R leg Fasciotomy
877204
189 Panchatsar 70 M 36 P > + 10 180 - + - - - + + k Cf,A,G GrII Ulcer L foot Slough Excision
877210
190 Rajrathinam 45 M 25 L N + 2 200 + - - + + - -  Path # L L IV toe dysarticulation
877741 IV toe
191 Sornamma 60 F 11 L N + 8 210 + - - - - + + Pr Cf,A,G GrII Ulcer L foot Slough Excision
877750
192 Rajakili 57 M 28 P > + 5 270 + - - - - - - Gangrene R R great toe
877900 Great toe Dysarticulation
193 Jayalaxmi 65 F 22 L N + 6 200 - - - - - + + Ec,Pr Cf,A,G GrII Ulcer R foot Slough Excision
878124
194 Janaki 60 F 22 L N + 5 180 + - - - - + - Ec Cf,A,G GrII Ulcer L foot Slough Excision
878124
195 Madasamy 58 M 14 P > + 8 180 - - - - - - - Cellulitis L leg Antibiotics
878190
196 Subbaih 68 M 17 P > + 10 230 - + - + - - + R III & IV Toe R III & IV toe
878600 Gangrene Dysarticulation
197 Saroja 50 F 25 L N + 4 200 - - - - - - - k Cf,G GrII Ulcer L foot Slough Excision
878650
198 Subramani 48 M 17 P > + 2 220 - + - + - - - R III toe R III Toe 
878700 Gangrene Dysarticulation
199 Kareem 40 M 17 P N + New 280 - - - - - - - Pr Cf,G GrII Ulcer L foot Slough Excision
878772 & SSG
200 Srinivasan 50 M 15 P > + 2 180 - - - - - - - Ec Cf,G GrII Ulcer R foot Slough Excision
878780 & SSG
